bioMerieux SA header image

bioMerieux SA

BIM

Equity

ISIN FR0013280286 / Valor 38147803

Euronext - Euronext Paris (2026-11-05)
EUR 94.75-2.97%

bioMerieux SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

bioMérieux SA is a global leader in the field of in vitro diagnostics, providing a wide range of diagnostic solutions to healthcare providers. The company specializes in the development, production, and marketing of diagnostic systems and services that are used in clinical applications. Among its innovative offerings, bioMérieux provides the VIDAS® KUBE™, an advanced automated immunoassay solution that enhances laboratory operations with its flexibility and cost-effectiveness. Additionally, the company offers SPOTFIRE®, a multiplex PCR solution tailored for point-of-care testing that delivers rapid, onsite actionable results, and VITEK® MS PRIME, which leverages mass spectrometry technology to improve daily laboratory workflows and patient care, particularly in the critical area of sepsis management. bioMérieux's commitment to advancing healthcare is evident in its comprehensive approach to sepsis management, offering solutions that support the entire process from antibiotic initiation through to appropriate discontinuation. Through its focus on innovation and efficiency, bioMérieux SA plays a crucial role in enhancing diagnostic capabilities and improving patient outcomes worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-12.6%1Y
0.37%3Y
-9.42%5Y

Performance

31.2%1Y
25.5%3Y
27.3%5Y

Volatility

Market cap

12459 M

Market cap (USD)

Daily traded volume (Shares)

267,669

Daily traded volume (Shares)

1 day high/low

103.1 / 102.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Orion Oyj
Orion Oyj Orion Oyj Valor: 2553360
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.60%EUR 101.00
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.09%EUR 85.86
Vimian Group AB
Vimian Group AB Vimian Group AB Valor: 111662981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%SEK 42.30
Medios AG
Medios AG Medios AG Valor: 19069483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.93%EUR 11.28
STERIS PLC
STERIS PLC STERIS PLC Valor: 47027903
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.50%USD 254.12
Cardinal Health Inc
Cardinal Health Inc Cardinal Health Inc Valor: 196652
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.25%USD 267.82
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.92%USD 19.72
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc West Pharmaceutical Services Inc Valor: 112491
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.99%USD 392.48
Lifco Ab
Lifco Ab Lifco Ab Valor: 111355378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.48%SEK 287.80
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Valor: 2676862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.28%SEK 493.60